Korro Bio, Inc.
KRRO
$14.48
$0.372.62%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.55M | 2.27M | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.55M | 2.27M | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.55M | 2.27M | -- | -- | -- |
| SG&A Expenses | 10.66M | 11.13M | 10.20M | 9.84M | 10.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.57M | 25.31M | 23.29M | 24.13M | 21.45M |
| Operating Income | -25.02M | -23.04M | -23.29M | -24.13M | -21.45M |
| Income Before Tax | -23.39M | -21.10M | -21.01M | -21.80M | -19.54M |
| Income Tax Expenses | -- | 103.00K | -9.00K | 30.00K | 17.00K |
| Earnings from Continuing Operations | -23.39M | -21.20M | -21.00M | -21.83M | -19.56M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.39M | -21.20M | -21.00M | -21.83M | -19.56M |
| EBIT | -25.02M | -23.04M | -23.29M | -24.13M | -21.45M |
| EBITDA | -23.80M | -21.79M | -22.43M | -23.40M | -20.73M |
| EPS Basic | -2.49 | -2.26 | -2.26 | -2.43 | -2.44 |
| Normalized Basic EPS | -1.56 | -1.41 | -1.41 | -1.52 | -1.52 |
| EPS Diluted | -2.49 | -2.26 | -2.26 | -2.43 | -2.44 |
| Normalized Diluted EPS | -1.56 | -1.41 | -1.41 | -1.52 | -1.52 |
| Average Basic Shares Outstanding | 9.38M | 9.37M | 9.30M | 8.99M | 8.02M |
| Average Diluted Shares Outstanding | 9.38M | 9.37M | 9.30M | 8.99M | 8.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |